期刊文献+

西酞普兰联合奥氮平治疗抑郁的临床疗效及对认知功能的影响 被引量:9

Clinical Efficacy of Citalopram Combined with Olanzapine in the Treatment of Depression and its Effects on Cognitive Function
下载PDF
导出
摘要 目的:探讨西酞普兰联合奥氮平治疗抑郁的临床疗效及对认知功能的影响。方法:选取我科在2017年2月至2018年6月门诊的抑郁症患者100例,随机分为两组,研究组使用西酞普兰30mgQD联合奥氮平1.25~2.25mgQN治疗,对照组单用西酞普兰30mgQD治疗,并分别予以HAMD-17项抑郁量表、PSQI睡眠量表及LOTCA认知功能成套测验比较分析两组患者治疗后临床疗效、睡眠改善程度及认知功能评分。结果:研究组临床症状改善显著优于对照组(P<0.05);研究组患者睡眠质量改善早于对照组并显著优于对照组(P<0.05);研究组治疗后多项认知功能评分优于对照组(P<0.05);研究组不良反应发生率与对照组无显著差异(P>0.05)。结论:在对中重度抑郁症患者的治疗过程当中,西酞普兰联合奥氮平治疗效果较好,为临床治疗提供新思路。 Objective:To explore the clinical efficacy of citalopram and olanzapine in the treatment of depression and its effects on cognitive function.Methods:Select 100 patients with depression from February 2017 to June 2018 in our hospital.Patients were randomly divided into two groups,the patients in the study group were treated with citalopram combined with olanzapine and thepatients in the control group was treated with only citalopram.The clinical efficacy and cognitive function of the two groups were compared after theropy.Results:The clinical efficacy of the study group was better than that of the control group(P<0.05).The sleeping quality of the patients in the study group was significantly better than that of the control group(P<0.05).The cognitive function of the group was better than that of the control group(P<0.05).There was noh no statistic difference in the incidence of adverse reactions between the study group and the control group(P>0.05).Conclusion:In the treatment of patients with depression,the effect of citalopram combined with olanzapine is ideal,which should be further popularized in clinic.
作者 范川 杨平 FAN Chuan(The First Affiliated Hospital of Medical University of Anhui,Anhui Hefei 230000,China)
出处 《河北医学》 CAS 2018年第10期1651-1656,共6页 Hebei Medicine
基金 安徽省高等学校自然科学研究重点项目 (编号:KJ2018A0659)
关键词 抑郁障碍 西酞普兰 奥氮平 临床疗效分析 认知功能 Depression Citalopram Olanzapine Clinical efficacy analysis Cognitive function
  • 相关文献

参考文献1

二级参考文献17

  • 1Kahn RS, Keefe RS. Schizophrenia is a cognitive illness : time for a change in tbcus[ Jl. JAMA Psychiatry, 2013,70(10) : 1107- 1112.
  • 2Bowie CR, Reichenberg A, Patterson TL, et al. Determinants of zal-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms [J]. Am J Psychiatry, 2006,163(3) :418-425.
  • 3Green MF, Nuechterlein KH, Kern RS, et al. Functional co- primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study[ J]. Am J Psyehiatry, 2008,165 ( 2 ) : 221-228.
  • 4Kern RS, Nuechterlein KH, Green MF, et al. The MATR1CS Consensus Cognitive Battery, part 2: co-norming and standardization [ J ]. Am J Psychiatry, 2008,165 ( 2 ) : 214-220.
  • 5Nuechterlein KH, Green MF, Kern RS, et al. The MATR1CS Consensus Cognitive Battery, part 1: test selection, reliability, and validity [ J ]. Am J Psychiat3,, 2008, 165 ( 2 ) : 203-213.
  • 6Fatouros-Bergman H, Cervenka S, Flyckt L, et al. Meta-analysis of cognitive performance in drug-nf've patients with schizophrenia [J]. SchizophrRes, 2014,158(1-3) :156-162.
  • 7刘娜,熊祥玉,应颖,等.首发精神分裂症患者治疗早期神经认知功能改变的对照研究[C]//中国神经科学学会精神病学基础与临床分会学术会议,2012.
  • 8Olivier MR, Killian S, Chiliza B, et al. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study[ J]. Psychol Med, 2015,45 ( 13 ) :2873-2883.
  • 9Cuesta M J, Jal6n EG, Campos MS, et al. Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis[ J ]. Br J Psychiatry, 2009, 194 ( 5 ) : 439-445.
  • 10Baddeley A. Working memory: theories, models, and controversies [ J ]. Annu Rev Psychol, 2012,63 : 1-29.

共引文献105

同被引文献107

引证文献9

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部